Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0142|120|15|2282-2288
ISSN: 0008-543x
Source: CANCER, Vol.120, Iss.15, 2014-08, pp. : 2282-2288
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Invasive cervical cancer remains an important global cause of death, despite the declining prevalence within the United States. Definitive therapies, including surgical resection of early‐stage disease and chemoradiation for locally advanced disease, can be curative. For women who experience local or distant recurrences, the prognosis remains poor and better treatments are required. On July 18, 2013, The Gynecologic Oncology Group sponsored a State of the Science in Cervical Cancer Symposium with experts, researchers, clinicians, and interested stakeholders. This article summarize the progress that has been made, questions that require further investigation, and contemporary genomic findings and innovative treatments that may help inform the next generation of clinical trials for patients with cervical cancer. Cancer 2014;120:2282–2288. © 2014 American Cancer Society.
Related content
Whither lung EIT: Where are we, where do we want to go and what do we need to get there?
By Adler Andy Amato Marcelo B Arnold John H Bayford Richard Bodenstein Marc Böhm Stephan H Brown Brian H Frerichs Inéz Stenqvist Ola Weiler Norbert Wolf Gerhard K
Physiological Measurement, Vol. 33, Iss. 5, 2012-05 ,pp. :
Rapid response systems: where we have come from and where we need to go?
JOURNAL OF NURSING MANAGEMENT, Vol. 26, Iss. 1, 2018-01 ,pp. :
Brainstem Tumors: Where Are We Today?
Pediatric Neurosurgery, Vol. 43, Iss. 3, 2007-04 ,pp. :
Hepatitis B: Where Are We Today?
Transfusion Medicine and Hemotherapy, Vol. 33, Iss. 5, 2006-09 ,pp. :